Interleukin-8-stimulated polyphosphoinositide hydrolysis in human peripheral blood lymphocytes

Area of Science:

• Immunology
• Cell Signaling
• Biochemistry

Background:

• Interleukin-8 (IL-8) is a key chemokine involved in immune responses.
• Understanding IL-8's signal transduction pathways in lymphocytes is crucial for immunology.
• Inositol phosphate (IP) metabolites are important second messengers in cellular signaling.

Purpose of the Study:

• To investigate if Interleukin-8 (IL-8) triggers inositol phosphate (IP) metabolite production in human peripheral blood lymphocytes (PBL).
• To characterize the kinetics and signaling components involved in IL-8-induced IP production.
• To compare IL-8's signaling effects with phytohemagglutinin (PHA) and assess the role of protein tyrosine kinases.

Main Methods:

• Peripheral blood lymphocytes (PBL) were loaded with [3H]-D-myo-inositol.
• Inositol phosphate (IP) metabolites were quantified using anion-exchange HPLC and liquid scintillation counting.
• Inositol-1,4,5-trisphosphate (IP3) was measured via a radioligand binding assay; protein tyrosine kinase inhibition was assessed using genistein.

Main Results:

• Human recombinant IL-8 (hrIL-8) significantly increased IP metabolites and IP3 levels in PBL, similar to phytohemagglutinin (PHA).
• IL-8-induced IP3 production peaked within 30 seconds.
• Genistein, a protein tyrosine kinase inhibitor, reduced IL-8- and PHA-stimulated IP3 generation by approximately 50%, indicating tyrosine kinase involvement.

Conclusions:

• Interleukin-8 (IL-8) effectively stimulates inositol phosphate (IP) metabolite production in human lymphocytes, signifying specific receptor-mediated signal transduction.
• The IL-8 signaling pathway in PBL involves protein tyrosine kinases.
• IL-8's effect on IP metabolite production is distinct from its minor impact on intracellular calcium levels.